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The objective of this study was to examine whether low
levels of oestradiol and testosterone are associated with impaired
mobility, low muscle strength and the incidence of falls in a




Cross-sectional population-based study, based on data of
the Longitudinal Ageing Study Amsterdam (LASA), including 623




Serum levels of oestradiol, testosterone, albumin
and sex hormone-binding globulin (SHBG) were measured. Physical
performance, functional limitations and muscle strength were





After adjustment for age, level of education, alcohol use,
physical activity, chronic disease and body mass index (BMI), men in
the highest quartile of the oestradiol/SHBG ratio had significantly





 = 0·103). Serum levels of total testosterone were positively




 = 0·085). Calculated bioavailable
testosterone levels were positively associated with physical per-




 = 0·128 and 0·109 respectively). No
associations of oestradiol levels with mobility were seen in women.




It can be concluded that low levels of sex hormones
were associated with impaired mobility and low muscle strength in
men, but not in women. Levels of sex hormones were not associated
with the incidence of falls neither in men, nor in women.
(Received 10 January 2005; returned for revision 4 March 2005; 
 




Falls and decline in mobility are major problems in the elderly.
Approximately 30% of the community-dwelling people aged
65 years and older fall at least once per year, and about 15% fall two




 The incidence of falls increases strongly with





may result in hip fracture, other fractures, soft tissue injury, or head
injury, and may cause fear of falling and functional decline. More-
over, falls are the third cause of chronic disability according to the




 Mobility limitations and




Serum concentrations of testosterone decrease with age in both





testosterone and oestradiol are mainly bound to sex hormone-binding
globulin (SHBG) and albumin. The free fraction and albumin-bound
part of testosterone and oestradiol are often called bioavailable (non-
SHBG-bound) testosterone and oestradiol, and are considered as the
fractions that are directly available for the target tissues. It remains
to be established whether total, non-SHBG-bound or free sex hormone
levels are the best representation of the bioactive concentrations.
The results of some studies suggest that low serum levels of hor-













 are associated with immobility and an increased risk




 on the effect of hormone replacement therapy
(HRT) reports a protective effect on the risk of falling among early




 the incidence of falls did
not differ between users and nonusers of oestrogen therapy. It is
unclear whether low levels of oestradiol in women are related to a
decrease in muscle strength. Studies on the effect of oestrogen therapy
on postural balance and muscle strength in women are contradictory.









Accumulating evidence suggests that in ageing men, low serum





 thereby increasing the risk of falls. Studies on the effect





 However, the association of testosterone with
muscle strength and poor mobility is not clear. Until recently, not
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much attention has been paid to the role of oestradiol in men. One
study found that oestradiol levels were not associated with muscle




The Longitudinal Ageing Study Amsterdam (LASA), including
similar numbers of men and women, is a prospective study in a
representative sample of community-dwelling elderly. In this
study, levels of oestradiol, testosterone, and a variety of other
measures were assessed.
The objective of this study was to examine whether low levels of
total and bioavailable oestradiol and testosterone were associated
with impaired mobility, low muscle strength and the incidence of






Data for this study were collected within the LASA, an ongoing
interdisciplinary cohort study on predictors and consequences of





 A random sample of men and women, aged 55 and
over, stratified by age, sex, urbanization and expected 5 years mor-
tality, was drawn from the population registers of 11 municipalities
in three regions of the Netherlands. The design of this study is pre-
sented in Fig. 1. In total, 3107 subjects were enrolled in the baseline
examination (1992/93). In the second data collection (1995/96),
2204 (71% of the original 3107 respondents) completed a main
interview. Attrition between the first and second cycle was mainly




All interviews were conducted by specially trained and intensively
supervised interviewers (main interview) and nurses (medical inter-
view), and were tape recorded in order to monitor the quality of the
data.
The present study was performed in a subgroup of the LASA,
including participants who completed a medical interview during
the second data collection (1995/96), including health-related





aged 65 years and older as of January 1, 1996. Of the 1720 eligible
respondents, 1509 (87·7%) took part in the medical interview. These
participants were invited to the VU University Medical Centre
(VUMC) or a health care centre where blood and urine samples were





 = 1321). Blood was put on ice immediately, and processed within
60 min. Levels of sex hormones, SHBG and albumin were deter-
mined in 1285 people. Subsequently, fall data were collected with a
fall calendar for 3 years in 1248 of these 1285 subjects. Informed con-
sent was obtained from all participants and the study was approved




Mobility included assessment of physical performance and self-
reported functional limitations. The performance tests included





back as fast as possible), chair stand test (time needed to stand up and
sit down five times with arms folded), and tandem stand (ability to





completing the walking test and chair stands were assigned scores
of 1–4, corresponding to the quartiles of time needed to complete
the test, with the fastest time scored 4. Those who could not complete
the test were assigned a score of 0. For the tandem stand, 0 points
were given to those who could not perform the tandem stand, 2
points to those who stood less than 10 s, and 4 points to those who





Self-reported functional limitations were assessed with a validated
questionnaire concerning the degree of difficulty with the following
six activities of daily living: climbing stairs, walking 5 min outdoors
without resting, getting up and sitting down in a chair, dressing and





 Participants who did not report any difficulty
with the activities were given a score of 0; those who had difficulty




Handgrip strength was measured using a strain-gauged dynamo-
meter (Takei TKK 5001, Takei Scientific Instruments Co. Ltd, Tokyo,
Japan). Participants were asked to perform two maximum force trials
with each hand. For the final scores, the maximum values of the right





strength has been found to correlate with strength of other muscle






For a period of 3 years, participants were asked to report their falls
on a fall calendar every week and to mail the calendar to the research


















they were unable to complete the fall calendar, if the calendar was
not returned even after a reminder, or if it was completed incorrectly.
A fall was defined as ‘an unintentional change in position resulting





faller’ was defined as a subject who fell at least two times in 6 months






Levels of testosterone, 17-beta-oestradiol and SHBG were obtained
during the examination in 1995/96 and kept frozen until deter-
mination. Testosterone concentrations were measured by radio
immunoassay (Coat-A-Count, DPC, Los Angeles, USA), with
intra-assay coefficients of variance (CV) of 16% at 1·5 nmol/ l and
7% at 5 nmol/ l, interassay CV was 11% at 2·6 nmol/ l and 7% at
11·5 nmol/ l; oestradiol concentrations were measured by radio
immunoassay (Diasorin Biomedica, Saluggia, Italy), with intra-assay
CV of 14% at 30 pmol/ l  and 7% at 100 pmol/ l, interassay CV was
10% at 70 pmol/ l. SHBG concentrations were measured by immu-
noradiometric assay (Orion Diagnostica, Espoo, Finland) with
intra-assay CV of 5% at 18 nmol/ l, interassay CV 6% at 10 nmol/ l.
The detection limits of testosterone, oestradiol and SHBG were
1 nmol/ l, 18 pmol/ l and 6 nmol/ l, respectively. Levels of testosterone
were not measured in women, as they were very low. We used various
measures of the levels of bioactive testosterone and oestradiol:
total testosterone and total oestradiol, testosterone/SHBG ratio,
oestradiol /SHBG ratio, calculated free testosterone and calculated
bioavailable (calculated free testosterone plus albumin-bound)
testosterone. Calculated free and bioavailable testosterone were








taking the concentration of testosterone, oestradiol, SHBG and
albumin into account. Calculated free oestradiol and bioavailable
oestradiol levels in women could not be determined, as levels of




Age is considered a possible effect modifier in the relationship
between sex hormones and falls, grip strength and mobility. It is pos-
sible that a stronger association of levels of sex hormones with mobil-
ity, grip strength and falls exists in older persons. Older people suffer
from muscle deterioration and often have mobility limitations.
Furthermore, they have fewer alternative mechanisms for preventing



































. Body weight was measured without clothes and
shoes using a calibrated balance beam scale. Height was measured
using a stadiometer. Alcohol use was assessed by asking the mean




 Education level was assessed
by asking the respondent for the highest education level completed,
ranging from incomplete elementary school to university education.
This was converted into years of education, which ranged from
5 to 18 years. Cognition was assessed with the mini-mental state





were measured with the Centre for Epidemiology Studies-














 Chronic diseases were
assessed by self-report during the main interview and included
pulmonary disease (asthma or chronic obstructive pulmonary
disease), cardiac disease, diabetes mellitus, arthritis, stroke and
peripheral atherosclerosis. The number of chronic diseases was
calculated. Physical activity was measured with the LASA physical
activity questionnaire (LAPAQ). The LAPAQ is a face-to-face ques-
tionnaire that covers the frequency and duration of walking outside,
bicycling, gardening, light household activities, heavy household





























 = 662). Subjects with low levels of
sex hormone were compared with those with high levels of sex




 tests for continuous variables, Mann–







dichotomized variables. The adjusted association between sex hor-
mones and mobility or muscle strength was examined using multiple
regression analysis. Associations are expressed as standardized
regression coefficients because this measure allows direct com-
parison of the strengths of the association between different
determinants with different outcome measures. The shape of the
associations was examined by dividing sex hormone levels into
quartiles. The relationship between sex hormones and several




 1 or more falls












 4 or more falls during




 5 or more falls during 3 years) was examined using
logistic regression analysis. Associations are expressed as odds
ratios with a 95% CI. All analyses were stratified by sex.
First, unadjusted analyses were performed. Second, the potential
confounders age, alcohol use, level of education and physical activity
were added to the model. Then, the potential confounder BMI was
added to the model, and eventually cognition and depression. As no
significant change of the beta was seen when cognition and depression








 = 1285) comprised 623 men and 662 women.
Table 1 shows the differences in the dependent variables between
men and women. Men scored significantly better on the mobility
measures (physical performance and functional limitations) and




 0·001). There was no gender





















Table 2 shows differences in potential confounders and dependent
variables between the lowest and highest quartiles of levels of oestra-
diol (in men and women) and testosterone (in men). Men with low
levels of testosterone scored significantly lower on physical perform-
ance and muscle strength and higher on functional limitations when
compared with men with high levels of testosterone. Men with low
levels of total testosterone were older, significantly less active, lower
educated and had a higher BMI than men with high levels of total
testosterone. Men with low levels of oestradiol had significantly
more functional limitations, had lower BMI and had more depres-
sive symptoms. Women with low levels of oestradiol had signific-
antly fewer functional limitations, fewer chronic diseases and better
physical performance than women with high levels of oestradiol.
They were younger and had a lower BMI. Differences in the fre-
quency of those with two or more falls in 6 months were not
observed.
The associations between total oestradiol and physical perform-
ance, functional limitations and grip strength are shown in Table 3.
In men, levels of total oestradiol were not associated with physical
performance, functional limitations or muscle strength. In women,
unadjusted analysis showed associations of total oestradiol with
physical performance and functional limitations. The associations
disappeared after adjustment for age, alcohol use, education level,
physical activity, chronic disease and BMI. After adjustment, men in
the fourth quartile of the oestradiol/SHBG ratio had a significantly





data not shown). In women, levels of oestradiol/SHBG were not
associated with physical performance, functional limitations or
muscle strength.
Table 4 shows the associations of total testosterone with physical
performance, functional limitations and muscle strength in men.
Levels of total testosterone were associated with physical perform-
ance, functional limitations and muscle strength. After adjustment,
total testosterone levels were significantly associated with muscle
strength. Unadjusted analysis showed that testosterone/SHBG
and calculated free testosterone were associated with physical
performance, functional limitations and muscle strength (data not
shown). After adjustment, testosterone/SHBG and calculated free
testosterone were associated with physical performance.
Levels of calculated bioavailable testosterone were positively
associated with physical performance, functional limitations and
muscle strength (Fig. 2). After adjustment, bioavailable testosterone
was no longer associated with functional limitations. Men in the
highest quartile of bioavailable testosterone had a better perform-
ance score and more muscle strength than men in the lowest quartile.
Table 5 shows the associations of levels of total oestradiol and
testosterone with falls. Unadjusted analysis showed that total oestradiol
and total testosterone were not associated with recurrent falling. The
oestradiol/SHBG ratio, testosterone/SHBG ratio, free fraction of
testosterone and bioavailable testosterone levels were significantly
associated with recurrent falling in men, but not in women (data not
shown). After adjustments for age, alcohol, education, BMI, chronic
disease and physical activity, no associations were observed between
levels of serum sex hormones and recurrent fallers among men and
women. When the sex hormone levels were divided in quartiles, no
trend was seen. Moreover, there were no associations between


















 4 or more falls









Ageing is associated with a reduction of levels of oestradiol and
testosterone in men and women. This may contribute to the greater
risk of poor mobility and falls in older people. This study included
a large sample of both men and women. To examine our hypothesis,
we used both objective tests and self-reports of mobility, and
we collected prospective fall data.
The results of this study suggest that low levels of oestradiol and
testosterone are associated with impaired mobility and low muscle
strength in men, but not in women. We did not observe an inde-
pendent association between levels of sex hormones and falls.


















a positive effect of oestrogen replacement therapy on falls, but only
in early menopausal women, suggesting that falls are particularly
related to early menopausal oestrogen deficiency.
We found a positive association of (total, free and bioavailable)
testosterone with muscle strength in older men. Our finding
that there is an association of testosterone with grip strength














 did not observe an improvement in hand grip





Table 1. Characteristics of outcome measures in men and women
 
Outcome measures N Male N Female P value*
Physical performance (range 0–10)† 596 6·46 ± 2·39 631 5·54 ± 2·60 < 0·001
Muscle strength (range 1–136)† 615 71·06 ± 16·58 647 41·98 ± 9·86 < 0·001
Functional limitations (range 0–6)‡ 616 0 [0–2] 650 1 [0–3] < 0·001
Two or more falls within 6 months§ 607 25·5 640 26·6  0·67
*Gender differences in mean values were examined with Student’s t test and Mann–Whitney test, frequencies with χ2-test; †results are presented in mean ± 






















































































Alcohol use (glasses/week)† 6 [5–21] 6 [1–21]  0·82 6 [1–20] 6 [1–21]  0·33 0·5 [0–3] 1 [0–6]  0·11


















































Physical activity (min/day)† 105 [49–184] 132 [75–186]  0·03 105 [60–186] 125 [71–176]  0·23 165 [108–225] 169 [109–240]  0·42










23‡ 20·5 12·8  0·06 20·8 16·4  0·3 13·9 21·8  0·06
Oestradiol, pmol/l 65·4 
 
± 21·8 89·6 ± 25·9 < 0·001 49·4 ± 9·4 110·7 ± 17·0 < 0·001 19·1 ± 2·5 50·2 ± 15·7 < 0·001
Testosterone, nmol/l 9·6 ± 2·6 21·8 ± 3·0 < 0·001 12·9 ± 4·8 18·3 ± 4·8 < 0·001 – – –
Phys. performance (range 0–10) 6·1 ± 2·5 6·9 ± 2·3  0·008 6·3 ± 2·7 6·5 ± 2·1  0·36 6·0 ± 2·7 4·8 ± 2·4 < 0·001
Muscle strength (range 10–136) 67·8 ± 16·3 74·0 ± 15·8  0·001 69·2 ± 15·9 71·3 ± 15·8  0·22 42·4 ± 10·4 40·9 ± 9·4  0·16
Funct. limitations (range 0–6)† 1 [0–2] 0 [0–1]  0·03 1 [0–2] 0 [0–1]  0·003 1 [0–2] 2 [1–4] < 0·001
Two or more falls within 6 months‡ 22·7 23·2  0·43 30·3 27·1  0·13 28·6 26·4  0·41
All differences are measured in mean ± standard deviation, unless stated otherwise. *Differences in mean values between highest and lowest quartile were examined with Student’s t test, in median 
with Mann–Whitney, in frequencies with χ2-test. †Results are presented in median [interquartile range]; ‡results are presented in percentages.
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a positive effect of testosterone administration on muscle strength,
and on hand grip strength in particular.43 It is difficult to compare these
studies on effects of testosterone treatment, because of differences
in type of androgen, length of treatment and type of administration
(patch or injection).
No adjusted associations could be found of total oestradiol and
the oestradiol/SHBG ratio with mobility or muscle strength in older
women. Observational studies on the effect of oestradiol on muscle
strength are scarce. Two studies did not observe an association
between oestradiol and muscle strength.17,18 Many postmenopausal
women have used oestrogen therapy to maintain adequate oestrogen
levels crucial for the preservation of bone mass.44 One study16 did
not find a significant increase in hand grip strength in women
using oestrogen, while another study13 showed that oestrogen
therapy resulted in a 15% increase in muscle strength. This increase
Table 3. Results of unadjusted and adjusted multiple regression analyses of total levels of serum oestradiol with physical performance, functional limitations 






















Unadjusted β β β β β β
Total oestradiol 0·013 −0·044 0·021 −0·150*** 0·171*** −0·045
Categories:
Q1 Reference Reference Reference Reference Reference Reference
Q2 0·035 −0·059 0·091 −0·041 0·080 0·006
Q3 0·010 −0·050 0·041 −0·057 0·099* −0·018
Q4 0·033 −0·076 0·048 −0·190*** 0·232*** −0·069
Adjusted†
Total oestradiol 0·039 −0·056 0·023 −0·054 0·040 −0·051
Categories:
Q1 Reference Reference Reference Reference Reference Reference
Q2 0·002 −0·026 0·035 −0·008 0·030 −0·009
Q3 0·028 −0·054 0·043 0·016 0·016 0·001
Q4 0·045 −0·076 0·031 −0·059 0·062 −0·051
*P < 0·05; *** P < 0·001; Q = quartile; †adjusted for age, alcohol use, education level, physical activity, number of chronic diseases and body mass index.
Table 4. Results of multiple regression analysis of total levels of serum 













Total testosterone 0·144*** −0·091* 0·130**
Categories:
Q1 Reference Reference Reference
Q2 0·050 −0·066 0·097
Q3 0·075 −0·029 0·089
Q4 0·136** −0·134** 0·166**
Adjusted†
Total testosterone 0·061 − 0·007 0·085*
Categories:
Q1 Reference Reference Reference
Q2 0·008 −0·030 0·087*
Q3 0·006 0·045 0·066
Q4 0·042 −0·046 0·135**
*P < 0·05; **P < 0·01, ***P < 0·001; Q = quartile. †Adjusted for age, alcohol 
use, education level, physical activity, number of chronic diseases and body 
mass index.
Fig. 2 Associations of bioavailable testosterone (quartiles) with physical 
performance, functional limitations and muscle strength. **P < 0·001; 
*P < 0·01; Q = quartile; gray bars represent unadjusted regression 
coefficients; white bars represent regression coefficients adjusted for age, 
alcohol use, education level, physical activity, number of chronic diseases and 
body mass index.
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is relatively small, compared to increases (30%) reported in resist-
ance training studies.45
The results in the group of women are opposite to the results we
expected. Table 3 shows negative, but nonsignificant, associations of
oestradiol levels and oestradiol/SHBG ratio with physical perform-
ance and muscle strength. This implies that high serum levels
of oestradiol are risk factors for poor physical performance and low
muscle strength. Also, according to our results, women with high
levels of oestradiol have more functional limitations than women
with low levels. Possibly, these results can be explained by the fact
that these women have a high body mass index (BMI). As oestradiol
after menopause is mainly produced in adipose tissue, women with
a high BMI have higher levels of oestradiol. Because BMI is a risk
factor of impaired mobility, we believe that this explains the results
we found in this study.
Known adverse effects of hormone replacement therapy (HRT)
in postmenopausal women include an increased risk of breast cancer
and venous thromboembolism.46 Recently, Hays et al.47 showed that
the effect of HRT on quality of life in postmenopausal women was
not clinically meaningful. Because of the severe adverse effects of
hormone replacement therapy, and the modest benefits, the use of
HRT has declined considerably during the last years. Based on our
results, testosterone therapy in men might be useful to prevent age-
related immobility. However, large, long-term studies are needed to
prove the beneficial  effects and safety.
In this study, we used various measures of bioactive testosterone.
According to Van den Beld et al.17 bioavailable testosterone levels are
the best representation of the bioactive testosterone levels. This was
confirmed in our study, as the associations of total testosterone,
testosterone/SHBG ratio and free testosterone were not as strong as
the associations of bioavailable testosterone with mobility and muscle
strength.
Our study has several limitations. First, the respondents of this
study are a selective group of relatively healthy older men and
women, because the frailest respondents of the LASA were not able
to visit the hospital or a health care centre. If these nonresponders
had lower serum levels of (bioavailable) testosterone and oestradiol,
underestimation of the associations might have occurred. Second,
an under-report may have occurred in participants during the fall
follow-up. The falls were based on self-report, and older persons
tend to forget falls.
In conclusion, no association of sex hormones with falls was
found. Moreover, in women, no associations were found of oestra-
diol with mobility and muscle strength. In men, serum total testo-
sterone was positively associated with muscle strength, bioavailable
testosterone levels were positively associated with physical perform-
ance and muscle strength. The data do not support the use of
hormone replacement therapy in women, whereas more studies are
needed in men.
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